The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Celldemic Seqirus Pty Ltd
Product name
Celldemic
Sponsor
Accepted date
May-2024
Active ingredients
Influenza virus haemagglutinin
Proposed indication
For active immunisation in persons from 6 months of age, to prevent influenza disease caused by the influenza A virus.
Application type
A (new medicine)
Publication date
May-2024